Reproducibility and reliability of middle cerebral artery occlusion using a silicone-coated suture (Koizumi) in rats

Journal of the Neurological Sciences

Volumn 153, Issue 1, 1997, Pages 8-11

  Takano, Kentaro ^a   Tatlisumak, Turgut ^a   Bergmann, Andreas G ^a   Gibson, Daniel G Iii ^b   Fisher, Marc ^a  

^a Med Ctr Ctrl Massachusetts U   (United States)

^b Life Science and Bioengineering Center   (United States)

Author keywords

Experimental stroke; Focal ischemia; Middle cerebral artery; Rat; Suture

Indexed keywords

SILICONE;

ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; EXPERIMENTAL MODEL; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RAT; RELIABILITY; REPRODUCIBILITY; STROKE; SUTURE;

ANIMALS; BRAIN ISCHEMIA; CEREBRAL ARTERIES; DISEASE MODELS, ANIMAL; MALE; RATS; RATS, SPRAGUE-DAWLEY; SILICONES; SUTURES;

EID: 0031444569     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00184-6     Document Type: Article

References (25)

1. Belayev L., Alonso O.F., Busto R., Zhao W., Ginsberg M.D. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke. 27:1996;1616-1623.
2. Chopp M., Zhang R.L., Chen H., Li Y., Jiang N., Rusche J.R. Postischemic administration of an Anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke. 25:1994;869-876.
3. Fisher M., Meadows M.-E., Do T., Weise J., Trubetskoy V., Charette M., Finklestein S.P. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 15:1995;953-959.
4. Garcia J.H., Wagner S., Liu K.-F., Hu X.-J. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Stroke. 26:1995;627-635.
5. Karibe H., Chen J., Zarow G.J., Graham S.H., Weinstein P.R. Delayed induction of mild hypothermia to reduce infarct volume after temporary middle cerebral artery occlusion in rats. J. Neurosurg. 80:1994;112-119.
6. Kawamura S., Shirasawa M., Fukasawa H., Yasui N. Attenuated neuropathology by nilvadipine after middle cerebral artery occlusion in rats. Stroke. 22:1991;51-55.
7. Kim Y., Busto R., Dietrich W.D., Kraydieh S., Ginsberg M.D. Delayed postischemic hyperthermia in awake rats worsens the histopathological outcome of transient focal cerebral ischemia. Stroke. 27:1996;2274-2281.
8. Kohno K., Back T., Hoehn-Berlage M., Hossmann K.-A. A modified rat model of middle cerebral artery thread occlusion under electrophysiological control for magnetic resonance investigations. Magn. Reson. Imag. 13:1995;65-71.
9. Koizumi J., Yoshida Y., Nakazawa T., Ooneda G. Experimental studies of ischemic brain edema. 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn. J. Stroke. 8:1986;1-8.
10. Kuge Y., Minematsu K., Yamaguchi T., Miyake Y. Nylon monofilament for intraluminal middle cerebral artery occlusion in rats. Stroke. 26:1995;1655-1658.
11. Laing R.J., Jakubowski J., Laing R.W. Middle cerebral artery occlusion without craniectomy in rats. Which method works best? Stroke. 24:1993;294-298.
12. Lin T.-N., He Y.Y., Wu G., Khan M., Hsu C.Y. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 24:1993;117-121.
13. Markgraf C.G., Kraydieh S., Prado R., Watson B.D., Dietrich W.D., Ginsberg M.D. Comparative histopathologic consequences of photothrombotic occlusion of the distal middle cerebral artery in Sprague-Dawley and Wistar rats. Stroke. 24:1993;286-293.
14. Meadows M.-E., Fisher M., Minematsu K. Delayed treatment with a noncompetitive NMDA antagonist, CNS-1102, reduces infarct size in rats. Cerebrovasc. Dis. 4:1994;26-31.
15. Memezawa H., Zhao Q., Smith M.-J., Siesjö B.K. Hyperthermia nullifies the ameliorating effect of dizocilpine maleate (MK-801) in focal cerebral ischemia. Brain Res. 670:1995;48-52.
16. Minematsu K., Li L., Fisher M., Sotak C.H., Davis M.A., Fiandaca M.S. Diffusion-weighted magnetic resonance imaging: rapid and quantitative detection of focal brain ischemia. Neurology. 42:1992;235-240.
17. Minematsu K., Li L., Sotak C.H., Davis M.A., Fisher M. Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats. Stroke. 23:1992;1304-1311.
18. Minematsu K., Fisher M. MK-801 reduces extensive infarction after suture middle cerebral artery occlusion in rats. Cerebrovasc. Dis. 3:1993;99-104.
19. Minematsu K., Fisher M., Li L., Davis M.A., Knapp A.G., Cotter R.E., McBurney R.N., Sotak C.H. Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI. Neurology. 43:1993;397-403.
20. Takano K., Latour L.L., Formato J.E., Carano R.A.D., Helmer K.G., Hasegawa Y., Sotak C.H., Fisher M. The role of spreading depression in focal ischemia evaluated by diffusion mapping. Ann. Neurol. 39:1996;308-318.
21. Warner D.S., McFarlane C., Todd M.M., Ludwig P., McAllister A.M. Sevoflurane and halothane reduce focal ischemic brain damage in the rat. Anesthesiology. 79:1993;985-992.
22. Warner D.S., Martin H., Ludwig P., McAllister A., Keana J.F.W., Weber E. In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists. J. Cereb. Blood Flow Metab. 1995:1995;188-196.
23. Zea Longa E., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:1989;84-91.
24. Zhang R.L., Chopp M., Li Y., Zaloga C., Jiang N., Jones M.L., Miyasaka M., Ward P.A. Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology. 44:1994;1747-1751.
25. Zhang F., Casey R.M., Ross M.E., Iadecola C. Aminoguanitidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Stroke. 27:1996;317-323.